NCT04503590View on ClinicalTrials.gov

Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

August 11, 2022

Study Completion Date

August 11, 2022

Conditions

Glaucoma

Interventions

DEVICE

Minimally Invasive Micro Sclerostomy (MIMS)

The System is a surgical device, designed to create a drainage channel at the sclera-corneal junction . The drainage channel is created by a Stainless Steel surgical tool.

Trial Locations (1)

0048

S.V.Malayan'S Eye Center, Yerevan

All Listed Sponsors

lead

Sanoculis Ltd

INDUSTRY

NCT04503590 - Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study | Biotech Hunter | Biotech Hunter